Breaking News Instant updates and real-time market news.

OPTN

Optinose

$5.59

0.41 (7.92%)

16:06
08/12/19
08/12
16:06
08/12/19
16:06

Optinose reports Q2 EPS (66c), consensus (74c)

Reports Q2 revenue $6.68M, consensus $6.56M. "We delivered 51% quarter-over-quarter growth in the number of XHANCE prescriptions during the second quarter of 2019, making this the third consecutive quarter of 50% or greater prescription growth," stated CEO Peter Miller. "Our revenue growth in the second quarter was comparably strong at 68% and our first half average revenue per prescription is within our full year guidance range." Mr. Miller also noted, "Our focus is on execution of our commercial strategy which is succeeding based on the launch performance of XHANCE. As one highlight, we are encouraged by the initial progress of the territory managers we hired in April to expand our physician reach by 25%. We expect these newly staffed territories to be one of several important drivers that can increase the number of patients starting treatment with XHANCE. Finally, what is more exciting than the growth we have experienced to date is the substantial market opportunity that is still available for XHANCE."

  • 12

    Aug

OPTN Optinose
$5.59

0.41 (7.92%)

12/19/18
CANT
12/19/18
NO CHANGE
Target $27
CANT
Overweight
Optinose upside potential remains compelling, says Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes says that despite a "lumpy" Xhance launch, he remains confident in the peak sales potential of Xhance. The "strong" efficacy data will drive uptake and persistence, even if this may take longer than originally anticipated, Folkes tells investors in a research note. The analyst believes upside potential in shares of Optinose "remains compelling" and he keeps an Overweight rating on the name with a $27 price target.
03/07/19
RBCM
03/07/19
NO CHANGE
Target $25
RBCM
Outperform
Optinose price target lowered to $25 from $30 at RBC Capital
RBC Capital analyst Randall Stanicky lowered his price target on Optinose to $25 to reflect the changes in his model around the ramp of XHANCE as well as its label expansion efforts in chronic sinusitis with the first trial being underway. The analyst also keeps his Outperform rating on the shares, saying the launch momentum of XHANCE has been "encouraging" with "reason for optimism" for the program following the company's Q4 earnings call.
03/07/19
JEFF
03/07/19
NO CHANGE
Target $21
JEFF
Buy
Optinose strong prescription trends continued into 2019, says Jefferies
Jefferies analyst David Steinberg says Optinose reported "solid" Q4 results with "strong" Xhance prescription trends continuing into 2019. Importantly, the patient affordability program and positive physician experiences seem to be driving "healthy" prescription growth, Steinberg tells investors in a research note. The analyst lowered his price target for Optinose shares to $21 from $31 and keeps a Buy rating on the name.
04/23/19
PIPR
04/23/19
NO CHANGE
Target $29
PIPR
Overweight
Optinose shares attractively valued at $400M market cap, says Piper Jaffray
After traveling with management, Piper Jaffray analyst David Amsellem reiterates an Overweight rating on Optinose with a $29 price target. The analyst says he came away from the meetings with greater insight into Optinose's efforts to continue improving payer access to Xhance, the company's intranasal form of fluticasone incorporated in its novel delivery device. Commentary and prescription data points reinforced Amsellem's confidence that Optinose will ultimately achieve "significant commercial success" with Xhance over the long-term. The shares are attractively valued in the context of a market cap of around $400M, the analyst tells investors in a research note.

TODAY'S FREE FLY STORIES

TGI

Triumph Group

$22.70

0.19 (0.84%)

06:00
08/23/19
08/23
06:00
08/23/19
06:00
Downgrade
Triumph Group rating change  »

Triumph Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.17

0.155 (2.21%)

, BNPQY

BNP Paribas

$0.00

(0.00%)

06:00
08/23/19
08/23
06:00
08/23/19
06:00
Periodicals
Deutsche Bank to move up to 800 staff members to BNP Paribas, FT reports »

Deutsche Bank (DB) plans…

DB

Deutsche Bank

$7.17

0.155 (2.21%)

BNPQY

BNP Paribas

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$46.57

0.32 (0.69%)

05:57
08/23/19
08/23
05:57
08/23/19
05:57
Upgrade
Altria Group rating change  »

Altria Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,804.00

-19.19 (-1.05%)

05:52
08/23/19
08/23
05:52
08/23/19
05:52
Periodicals
Amazon to stop using tips to cover wages for Flex drivers, LA Times reports »

Amazon says it will no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

OXY

Occidental Petroleum

$44.69

-0.35 (-0.78%)

05:49
08/23/19
08/23
05:49
08/23/19
05:49
Initiation
Occidental Petroleum initiated  »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

LZB

La-Z-Boy

$31.52

1.48 (4.93%)

05:45
08/23/19
08/23
05:45
08/23/19
05:45
Upgrade
La-Z-Boy rating change  »

La-Z-Boy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

05:45
08/23/19
08/23
05:45
08/23/19
05:45
Downgrade
HP Inc. rating change  »

HP Inc. downgraded In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HCM

Hutchison China MediTech

$20.53

0.13 (0.64%)

05:34
08/23/19
08/23
05:34
08/23/19
05:34
Hot Stocks
Chi-Med initiates Phase I study of HMPL-523 »

Hutchison China MediTech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

SMSEY

Samsonite International

$0.00

(0.00%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Samsonite International management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

URBN

Urban Outfitters

$23.91

1.53 (6.84%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Urban Outfitters management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Nov

SERV

ServiceMaster

$58.21

0.37 (0.64%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
ServiceMaster management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 28

    Aug

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

04:55
08/23/19
08/23
04:55
08/23/19
04:55
General news
Breaking General news story  »

Federal Reserve Chairman…

GLOB

Globant

$96.92

3.21 (3.43%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Globant management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

04:55
08/23/19
08/23
04:55
08/23/19
04:55
General news
New Home Sales to be reported at 10:00 »

July New Home Sales will…

GKOS

Glaukos

$61.31

-1.71 (-2.71%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Glaukos management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 26

    Aug

  • 04

    Sep

  • 13

    Nov

AMAT

Applied Materials

$47.04

0.21 (0.45%)

, AMD

AMD

$31.90

0.2 (0.63%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
MUFG Securities to hold a tour »

MUFG Securities Tech Tour…

AMAT

Applied Materials

$47.04

0.21 (0.45%)

AMD

AMD

$31.90

0.2 (0.63%)

ANET

Arista Networks

$227.19

0.48 (0.21%)

CHKP

Check Point

$109.20

-0.01 (-0.01%)

CSCO

Cisco

$48.20

-0.59 (-1.21%)

EQIX

Equinix

$554.08

2.15 (0.39%)

FLEX

Flex

$10.26

0.26 (2.60%)

INTC

Intel

$46.76

-0.39 (-0.83%)

NVDA

Nvidia

$171.44

0.21 (0.12%)

OTEX

OpenText

$39.11

0.18 (0.46%)

PYPL

PayPal

$108.74

-1.09 (-0.99%)

RNG

RingCentral

$142.36

2.33 (1.66%)

SQ

Square

$64.65

-0.78 (-1.19%)

STX

Seagate

$47.58

0.36 (0.76%)

TWLO

Twilio

$130.48

-0.57 (-0.43%)

V

Visa

$180.15

-0.8 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Wolfe Research healthcare analysts to hold an analyst/industry webcast »

Global Pharma Analyst…

04:55
08/23/19
08/23
04:55
08/23/19
04:55
General news
Breaking General news story  »

Week of 8/23 Baker-Hughes…

CMS

CMS Energy

$62.13

0.04 (0.06%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
CMS Energy management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 29

    Aug

  • 10

    Nov

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Cowen retail analysts to hold an analyst/industry conference call »

Retail Analyst Chen,…

03:50
08/23/19
08/23
03:50
08/23/19
03:50
General news
FX Action: USD-CAD nudged out a three-day high »

FX Action: USD-CAD nudged…

03:05
08/23/19
08/23
03:05
08/23/19
03:05
General news
FX Update: The New Zealand dollar outperformed and China's yuan weakened »

FX Update: The New…

LLY

Eli Lilly

$111.63

0.2 (0.18%)

21:03
08/22/19
08/22
21:03
08/22/19
21:03
Hot Stocks
Arbitration panel rules in favor of Eli Lilly in Adocia IP claim »

A Chicago-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

  • 23

    Oct

FL

Foot Locker

$42.00

2.24 (5.63%)

, HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

20:25
08/22/19
08/22
20:25
08/22/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FL

Foot Locker

$42.00

2.24 (5.63%)

HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

RGR

Sturm, Ruger

$41.48

0.69 (1.69%)

, AOBC

American Outdoor Brands

$7.69

-0.01 (-0.13%)

19:40
08/22/19
08/22
19:40
08/22/19
19:40
Hot Stocks
Trump 'hopeful' to work with Congress on' legislation addressing mass shootings »

President Donald Trump…

RGR

Sturm, Ruger

$41.48

0.69 (1.69%)

AOBC

American Outdoor Brands

$7.69

-0.01 (-0.13%)

VSTO

Vista Outdoor

$5.33

0.26 (5.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 10

    Sep

  • 19

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.